• Most Popular
  • Most Shared

Human Genome says antiviral drug shows positive results

Tue Feb 27, 2007 4:45pm EST

Stocks

   

Feb 27 (Reuters) - Human Genome Sciences Inc. (HGSI.O) said a mid-stage trial of its antiviral drug Albuferon with ribavirin showed positive results in patients with chronic liver wasting disease, hepatitis C.

Regulatory News

The biotechnology company said the mid-stage results show that Albuferon may offer comparable or improved efficacy versus Roche Holding AG's (ROG.VX) Pegasys.

The company said it started late-stage trials of Albuferon, being developed with Novartis AG (NOVN.VX), in combination with ribavirin. (Reporting by Shivani Singh in Bangalore)

Regulatory News


More from Reuters

Joint Terminal Attack Controller SSgt Clinton J. Herbison, a U.S. Airman from the 817 Expeditionary Air Support Operations Squadron (EASOS) takes a break during a night mission near Honaker Miracle camp at the Pesh valley of Kunar Province August 12, 2009. Credit: REUTERS/Carlos Barria

Pictures of the Year

A look at the best photos of 2009.  Slideshow 

    PICTURES
    The Dalai Lama jokes with a nasal spray after being asked his opinion on the swine flu during a press conference after his first lecture in Lausanne, Switzerland, August 4, 2009. REUTERS/ Valentin Flauraud

    What a wacky year it's been...

    Um, what's up the Dalai Lama's nose? "Oddly Enough" editor Bob Basler rounds up the goofiest photos of the year.  Full Article 

    Oddly Enough
    A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
    Political Risk in 2010:

    Don't say we didn't warn you

    With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

    Global Markets